Trial Profile
Real-world Use and (Cost)-Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Early breast cancer; HER2 positive breast cancer; Male breast cancer
- Focus Therapeutic Use
- 08 Aug 2013 New trial record